Cannabis Law Report

JULY 23, 2021

On Wednesday, July 14, 2021 Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) released draft legislation titled the Cannabis Administration and Opportunity Act. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF).

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

JULY 28, 2022

Colorado could decriminalize the personal use and possession of certain psychedelic plants and fungi, including “magic mushrooms,” and create a Natural Medicine Access Program, according to a voter initiative on the November ballot. Oregon, two years ago, became the first state to legalize psilocybin with the approval of Measure 109.

Legalization 52

Legalization Decriminalization Food Safety 52

Cannabis Law Report

JULY 9, 2021

In June 2021, similar measures were passed in Connecticut and Texas, where medical research on psilocybin is now also legal on a statewide level. Joyce Cutler, Texas the Latest State to Legalize Psychedelic Medical Research, BLOOMBERG LAW (June 23, 2021), available at [link]. Drug Enforcement Agency (“DEA”). 21-70544, Dkt.

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JANUARY 13, 2022

1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. 14, 2021, alert ). 1, out-of-state medical marijuana patients may access Arkansas’ program to purchase cannabis for up to 90 days. This opinion follows a September 2021 guidance letter (see Nov.

Dispensary 52

Dispensary Law Concentrates Patients 52

Cannabis Law Report

DECEMBER 21, 2021

Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. It was officially listed on the NYSE in August and granted a DEA schedule I manufacturing license in November.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JUNE 1, 2021

Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results. Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Fourth Quarter Fiscal 2021 Financial Summary. (in Fiscal Year 2021 Financial Summary. (in Net revenue. 2,800) bps.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

NOVEMBER 2, 2021

Oracle wrote 21 October 2021. The investigation covered a lot of important ground, but the main results concern the levels of delta-9 THC in each product, the inaccuracy of the labeling, how easily minors can get access to products and whether companies test for impurities. Michigan (comes into effect October 2021). Methodology.

THC 96

THC CBD Legalization Vaping 96

The Herb Collective

JUNE 25, 2018

"Every year, about 98% of all of the grass removed by the DEA's "Domestic Cannabis Eradication/Suppression Program" is really hemp." billion by 2021, according to a report by Arcview Market Research. The remaining $1.1 billion was spent on abuse and addiction studies. " Hemp contains less than 1% of THC.

Marijuana 56

Marijuana Edibles Recreational Strains 56

Veriheal

AUGUST 19, 2022

” Cannabis Research Should Be Based on Real, Accessible Products. In February 2021, a lawsuit was filed against the DEA for prohibiting access for others aside from the University of Mississippi to cultivate cannabis for research purposes. Could hemp replace plastics? Yes, without a doubt. Yes, according to many.

Hemp 52

Hemp DEA Access Cultivation 52

Project CBD

AUGUST 23, 2023

has shrunk by 48 percent since 2021. 23 Yet this conversion is occurring without regulatory oversight to ensure process standardization, product specification, and accurate third-party testing, all of which are mandated in state-licensed cannabis programs. But the opposite is true. The amount of hemp under cultivation in the U.S.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

APRIL 13, 2022

market presence, complementary client programming and respected clinical research capabilities allow us to accelerate our strategic growth plans and broaden access to healing and wellness.” Increased client programming with complementary service offerings to be shared and expanded across the combined clinic network.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

Cannabis Law Report

JUNE 9, 2021

That means no matter the potency of your product, and whether you’re traveling with gummies, a vape pen, processed flower, or even the living plants themselves, in the eyes of the law, you are officially Moving With Marijuana™ Where is recreational marijuana legal in 2021? Where is medical marijuana legal in 2021? Connecticut.

Marijuana 66

Marijuana Edibles DEA THC 66

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) today announces its financial results for the first quarter fiscal 2022 ended June 30, 2021.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. Lyle Craker, Ph.D., Reddit awarded $82,765.95

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. THC vs CBD.

THC 98

THC Research and Development Cannabinoids CBD 98

NORML

FEBRUARY 18, 2020

The latest offense is his recently released 2021 federal budget proposes slashing all legal protection for state medical marijuana programs and potentially jeopardizing the patients that rely on them. Sign our petition to demand Congress protect state-legal medical marijuana programs. The data speaks for itself.

Marijuana 353

Marijuana DEA Programs Patients 353

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. Some states that have passed recreational or medical marijuana legislation are still negotiating the details for implementing these programs.

Recreational 52

Recreational Data Cannabis DEA 52

Cannabis Law Report

AUGUST 5, 2021

Aug 4, 2021 . As everyone in the cannabis industry now knows, on July 14, 2021, Senate Majority Leader Chuck Schumer (D-NY) introduced the long awaited proposed Cannabis Administration and Opportunity Act , weighing in at 163 pages. The fate of the SAFE Banking Act to enhance banking access for cannabis companies, which Sen.

Banking 111

Banking Vaping Education DEA 111

Cannabis Law Report

JULY 14, 2021

— Ron Wyden (@RonWyden) July 14, 2021. Big companies already have access to these services, and delaying that same access for small businesses would not further the goal of fostering a more diverse and inclusive industry. July 14, 2021 Friends, Today, we are saying, “The days of federal prohibition are numbered.”

Legislation 71

Legislation Banking History Access 71

Nature's Way Medicine

FEBRUARY 12, 2021

The DEA would be mandated to approve applications for manufacturers to produce marijuana-derived, FDA-approved drugs. The program has 160,000 registered patients and about 700 doctors certified to recommend marijuana. Despite this growth, there is concern that the marijuana program in Ohio is not growing as rapidly as it could.

Research and Development 97

Research and Development Patients CBD DEA 97

SpeedWeed

JULY 15, 2021

The 163-page Cannabis Administration and Opportunity Act (CAOA) aims to remove cannabis from the list of controlled substances; tax and regulate cannabis at the federal level; and grant states the power to keep or administer their own oversight programs. . “This is cannabis common sense,” Wyden said during the press conference.

Banking 52

Banking Programs Decriminalization Legislation 52

SpeedWeed

JULY 15, 2021

The 163-page Cannabis Administration and Opportunity Act (CAOA) aims to remove cannabis from the list of controlled substances; tax and regulate cannabis at the federal level; and grant states the power to keep or administer their own oversight programs. . “This is cannabis common sense,” Wyden said during the press conference.

Business 52

Business Banking Programs Decriminalization 52

SpeedWeed

JULY 15, 2021

The 163-page Cannabis Administration and Opportunity Act (CAOA) aims to remove cannabis from the list of controlled substances; tax and regulate cannabis at the federal level; and grant states the power to keep or administer their own oversight programs. . “This is cannabis common sense,” Wyden said during the press conference.

Banking 52

Banking Programs Decriminalization Legislation 52

SpeedWeed

JULY 14, 2021

The 163-page Cannabis Administration and Opportunity Act (CAOA) aims to remove cannabis from the list of controlled substances; tax and regulate cannabis at the federal level; and grant states the power to keep or administer their own oversight programs. . “This is cannabis common sense,” Wyden said during the press conference.

Packaging 52

Packaging Banking Programs CBD 52